|3.03||+0.99 / +48.53%|
As of 3:59pm ET
|3.10||+0.07 / +2.31%|
The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 64.00 and a low estimate of 64.00. The median estimate represents a +2,012.21% increase from the last price of 3.03.
The current consensus among 1 polled investment analysts is to Buy stock in KaloBios Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.